MAZE Q2 2025 Earnings — Maze Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

MAZEMaze Therapeutics, Inc.

$2B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$649,000

Operating Income

-$36M

Net Income

-$34M

EPS (Diluted)

$-0.77

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$304M

Total Liabilities

$41M

Stockholders' Equity

$262M

Cash & Equivalents

$265M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$165M	-100.0%
Gross Profit	-$649,000	$165M	-100.4%
Operating Income	-$36M	$140M	-126.1%
Net Income	-$34M	$139M	-124.2%